Key result
Doppler microembolic signals varied by prosthetic valve type but showed no significant difference in prevalence between neurologically symptomatic and asymptomatic patients.
Why the study?
Do Doppler microembolic signals correlate with neurological complications in patients with prosthetic cardiac valves?
Observational (n=580)
Yes
Do Doppler microembolic signals correlate with neurological complications in patients with prosthetic cardiac valves?
Doppler microembolic signals in patients with prosthetic cardiac valves depend on valve type but do not correlate with neurological symptoms, suggesting they lack direct clinical significance.
Answers are grounded in this paper and cite their sources.
Microembolic signals lack symptom correlation and should not yet change practice; leaves open their investigation as valve-type-specific biomarkers.
BACKGROUND: The clinical relevance of Doppler microembolic signals (MES) in patients with prosthetic cardiac valves was evaluated by merging and statistically reanalyzing patient data from four research institutions (Departments of Neurology, Universities of Aachen, Halle, and Münster, Germany; Department of Medicine and Therapeutics, University of Glasgow, Scotland, and Department of Cardiothoracic Surgery, Western Infirmary, Glasgow, Scotland). METHODS: Transcranial Doppler monitoring for MES was performed over the middle cerebral arteries for 30 to 60 minutes per patient. Prevalence of neurological complications was evaluated with a standard neurological questionnaire in patients carrying the valve implant longer than 3 months (n=369). RESULTS: Significant differences in MES prevalence and counts were noted among the 580 patients depending on valve type (presented with medians and [95% confidence intervals]): St Jude Medical, n=200, 72%, 4 [3 to 6]; Björk Shiley Monostrut, n=99, 92%, 133 [93 to 181]; Medtronic Hall, n=80, 47%, 1 [2 to 5]; ATS, n=61, 52%, 3 [2 to 5]; Tecna, n=38, 71%, 2 [1 to 4]; Carbomedics, n=37, 81%, 8 [5 to 13]; Carpentier-Edwards supraannular, n=54, 39%, 1 [0 to 3]; Sorin biological, n=11, 9%, 0 [0 to 0]. No relation between MES counts and valve size, international normalized ratio, patients' age, cardiac rhythm, or implant duration was noted. No significant differences in MES counts or prevalence (22 [3 to 68] versus 5 [3 to 6] and 63% versus 69%, both P>.05), in valve duration, valve position, valve type, patients' age, sex, cardiac rhythm, or international normalized ratio were evident between neurologically symptomatic (n=42) and asymptomatic patients. CONCLUSIONS: MES in patients with prosthetic cardiac valves depend on the type and, in certain valve types, the position of the valve implant and possess no direct clinical significance.
No takes yet. Share an insight, caveat, or question.
Sliwka et al. (1998) conducted an observational in Prosthetic cardiac valves (n=580). Prosthetic cardiac valves vs. Different valve types was evaluated on Microembolic signal (MES) prevalence in neurologically symptomatic versus asymptomatic patients (p=>.05). Doppler microembolic signals varied by prosthetic valve type but showed no significant difference in prevalence between neurologically symptomatic and asymptomatic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: